Text Size: A A A      Contrast:       
 

Dr. Singerman appointed to scientific advisory boards

Lawrence Singerman, MD, FACS, FICS, has been appointed to numerous scientific advisory boards, including ArcticDX Inc., Ohr Pharmaceuticals, and Valeant Pharmaceuticals, which have developed approaches that could significantly advance treatment options for patients suffering from AMD.ArcticDX has developed the Macula Risk NXG test for predicting the risk of AMD progression through the evaluation of genetics along with the clinical assessment of AMD patients.